Medios AG
0QB4.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$251.43M
Close$
$28.32
176% upside
Current Fair Value
176% upsideUndervalued by 176% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $251.43 Million |
|---|---|
| Enterprise Value | $368.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.61 |
| Beta | 1.21 |
| Outstanding Shares | 24,505,723 |
Return
| Return on Equity | 2.14% |
|---|---|
| Return on Assets | 1.22% |
| Return on Invested Capital | 5.89% |
Valuation & Multiples
| P/E Ratio | 23.45 |
|---|---|
| PEG | -53.62 |
| Price to Sales | 0.12 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 0.17 |
| Enterprise Value to EBIT | 8.73 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$547.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medios AG
982 employees
CEO: Thomas Meier Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuse...